NASDAQ:SSKN

Strata Skin Sciences (SSKN) Stock Price, News & Analysis

Strata Skin Sciences logo
$0.0001 0.00 (0.00%)
As of 11/18/2026 03:14 PM Eastern

About Strata Skin Sciences Stock (NASDAQ:SSKN)

Advanced

Key Stats

Today's Range
$0.0001
▼
$0.0001
50-Day Range
N/A
52-Week Range
$0.00
▼
$1.53
Volume
284 shs
Average Volume
167,780 shs
Market Capitalization
$588.80
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Sell

Company Overview

STRATA Skin Sciences, Inc. is a medical technology company focused on developing and commercializing devices for the treatment of dermatological conditions. Its products are used by dermatologists and other healthcare providers in clinical settings.

The company’s portfolio includes the XTRAC excimer laser and VTRAC excimer lamp, which deliver targeted ultraviolet light for conditions such as psoriasis and vitiligo. STRATA also offers the TheraClearX system, a device-based treatment for acne.

STRATA was previously known as MELA Sciences and adopted its current name in 2016 as it shifted its focus toward dermatology treatment technologies. It serves customers in the United States and sells its products in international markets through distribution partners.

AI Generated. May Contain Errors.

Strata Skin Sciences Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
2nd Percentile Overall Score

SSKN MarketRank™: 
0.108874281015 of 5 stars

Strata Skin Sciences scored higher than 2% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Strata Skin Sciences has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Strata Skin Sciences has received no research coverage in the past 90 days.

  • Read more about Strata Skin Sciences' stock forecast and price target.
  • Earnings Growth

    Earnings for Strata Skin Sciences are expected to grow in the coming year, from ($1.05) to ($1.04) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Strata Skin Sciences is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Strata Skin Sciences is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Strata Skin Sciences has a P/B Ratio of 0.00. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Strata Skin Sciences' valuation and earnings.
  • Short Interest

    There is no current short interest data available for SSKN.
  • Dividend Yield

    Strata Skin Sciences does not currently pay a dividend.

  • Dividend Growth

    Strata Skin Sciences does not have a long track record of dividend growth.

  • News Coverage This Week

    MarketBeat has tracked 1 news article for Strata Skin Sciences this week, compared to 0 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Strata Skin Sciences insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    40.92% of the stock of Strata Skin Sciences is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    32.43% of the stock of Strata Skin Sciences is held by institutions.

  • Read more about Strata Skin Sciences' insider trading history.
Receive SSKN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Strata Skin Sciences and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SSKN Stock News Headlines

Strata Skin Sciences (SSKN) Projected to Announce Earnings on Tuesday
Pentagon magnet restrictions take effect January 1, 2027
A NASDAQ-listed company has signed a term sheet outlining a potential 75-year agreement with the U.S. Army. It would build and operate a rare earth processing facility on an active military base, with the Army receiving first right to production. The timing matters. New Pentagon restrictions on certain Chinese-origin rare earth magnets take effect January 1, 2027, while China controls more than 90% of global rare earth processing. The company's mine-to-magnet platform spans feedstock agreements, processing facilities, metallization technology, and downstream manufacturing, with initial commercial output targeted for 2027.tc pixel
STRATA Skin Sciences Confirms Nasdaq Delisting
See More Headlines

SSKN Stock Analysis - Frequently Asked Questions

Strata Skin Sciences' stock was trading at $1.26 at the start of the year. Since then, SSKN stock has decreased by 100.0% and is now trading at $0.0001.

Strata Skin Sciences, Inc. (NASDAQ:SSKN) announced its quarterly earnings results on Thursday, November, 13th. The medical device company reported ($0.36) EPS for the quarter, missing analysts' consensus estimates of ($0.24) by $0.12. The medical device company had revenue of $6.93 million for the quarter, compared to analyst estimates of $7.72 million. Strata Skin Sciences had a negative trailing twelve-month return on equity of 476.73% and a negative net margin of 35.64%.
Read the conference call transcript
.

Strata Skin Sciences's stock reverse split before market open on Friday, June 7th 2024.The 1-10 reverse split was announced on Friday, June 7th 2024. The number of shares owned by shareholders was adjusted after the market closes on Friday, June 7th 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Shares of SSKN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Strata Skin Sciences investors own include Tesla (TSLA), GE Aerospace (GE), Ford Motor (F), Amarin (AMRN), Plug Power (PLUG), Advanced Micro Devices (AMD) and Gevo (GEVO).

Company Calendar

Today
11/18/2026
Next Earnings (Estimated)
11/18/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
NASDAQ:SSKN
CIK
1051514
Employees
120
Year Founded
1989

Profitability

EPS (Trailing Twelve Months)
($1.41)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$10.09 million
Net Margins
-35.64%
Pretax Margin
-36.34%
Return on Equity
-476.73%
Return on Assets
-33.49%

Debt

Debt-to-Equity Ratio
10.22
Current Ratio
0.95
Quick Ratio
0.75

Sales & Book Value

Annual Sales
$30.98 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.19 per share
Price / Book
0.00

Miscellaneous

Outstanding Shares
5,888,000
Free Float
3,479,000
Market Cap
$588.80
Optionable
Not Optionable
Beta
0.33

Social Links

7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

This page (NASDAQ:SSKN) was last updated on 11/18/2026 by MarketBeat.com Staff.
From Our Partners